메뉴 건너뛰기




Volumn 66, Issue 15, 2015, Pages 1672-1682

Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure with Preserved Ejection Fraction

Author keywords

cardiac output; nitrate; pressure; stroke volume

Indexed keywords

PLACEBO; SODIUM NITRITE;

EID: 84943264616     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.07.067     Document Type: Article
Times cited : (189)

References (38)
  • 1
    • 79952829685 scopus 로고    scopus 로고
    • Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment
    • B.A. Borlaug, and W.J. Paulus Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment Eur Heart J 32 2011 670 679
    • (2011) Eur Heart J , vol.32 , pp. 670-679
    • Borlaug, B.A.1    Paulus, W.J.2
  • 2
    • 77957907689 scopus 로고    scopus 로고
    • Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction
    • B.A. Borlaug, R.A. Nishimura, P. Sorajja, and et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ Heart Fail 3 2010 588 595
    • (2010) Circ Heart Fail , vol.3 , pp. 588-595
    • Borlaug, B.A.1    Nishimura, R.A.2    Sorajja, P.3
  • 3
    • 77956324154 scopus 로고    scopus 로고
    • Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction
    • M.T. Maeder, B.R. Thompson, H.P. Brunner-La Rocca, and D.M. Kaye Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction J Am Coll Cardiol 56 2010 855 863
    • (2010) J Am Coll Cardiol , vol.56 , pp. 855-863
    • Maeder, M.T.1    Thompson, B.R.2    Brunner-La Rocca, H.P.3    Kaye, D.M.4
  • 4
    • 79956313657 scopus 로고    scopus 로고
    • Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction
    • B.A. Borlaug, W.A. Jaber, S.R. Ommen, and et al. Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction Heart 97 2011 964 969
    • (2011) Heart , vol.97 , pp. 964-969
    • Borlaug, B.A.1    Jaber, W.A.2    Ommen, S.R.3
  • 5
    • 84929899802 scopus 로고    scopus 로고
    • Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: The role of abnormal peripheral oxygen extraction
    • B.P. Dhakal, R. Malhotra, R.M. Murphy, and et al. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction Circ Heart Fail 8 2015 286 294
    • (2015) Circ Heart Fail , vol.8 , pp. 286-294
    • Dhakal, B.P.1    Malhotra, R.2    Murphy, R.M.3
  • 6
    • 84924313055 scopus 로고    scopus 로고
    • A central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: Implications for heart failure with preserved ejection fraction
    • M. Santos, A.R. Opotowsky, A.M. Shah, and et al. A central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fraction Circ Heart Fail 8 2014 278 285
    • (2014) Circ Heart Fail , vol.8 , pp. 278-285
    • Santos, M.1    Opotowsky, A.R.2    Shah, A.M.3
  • 7
    • 84939461162 scopus 로고    scopus 로고
    • Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction
    • V.P. van Empel, J. Mariani, B.A. Borlaug, and D.M. Kaye Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction J Am Heart Assoc 3 2014 e001293
    • (2014) J Am Heart Assoc , vol.3 , pp. e001293
    • Van Empel, V.P.1    Mariani, J.2    Borlaug, B.A.3    Kaye, D.M.4
  • 8
    • 84925031704 scopus 로고    scopus 로고
    • Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure
    • M.J. Andersen, T.P. Olson, V. Melenovsky, and et al. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure Circ Heart Fail 8 2015 41 48
    • (2015) Circ Heart Fail , vol.8 , pp. 41-48
    • Andersen, M.J.1    Olson, T.P.2    Melenovsky, V.3
  • 9
    • 84913593417 scopus 로고    scopus 로고
    • Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction
    • S. Dorfs, W. Zeh, W. Hochholzer, and et al. Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction Eur Heart J 35 2014 3103 3112
    • (2014) Eur Heart J , vol.35 , pp. 3103-3112
    • Dorfs, S.1    Zeh, W.2    Hochholzer, W.3
  • 10
    • 84877942509 scopus 로고    scopus 로고
    • Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction
    • M.M. Abudiab, M.M. Redfield, V. Melenovsky, and et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction Eur J Heart Fail 15 2013 776 785
    • (2013) Eur J Heart Fail , vol.15 , pp. 776-785
    • Abudiab, M.M.1    Redfield, M.M.2    Melenovsky, V.3
  • 11
    • 77956330748 scopus 로고    scopus 로고
    • Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction
    • B.A. Borlaug, T.P. Olson, C.S. Lam, and et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction J Am Coll Cardiol 56 2010 845 854
    • (2010) J Am Coll Cardiol , vol.56 , pp. 845-854
    • Borlaug, B.A.1    Olson, T.P.2    Lam, C.S.3
  • 12
    • 84865209443 scopus 로고    scopus 로고
    • Low myocardial protein kinase g activity in heart failure with preserved ejection fraction
    • L. van Heerebeek, N. Hamdani, I. Falcao-Pires, and et al. Low myocardial protein kinase g activity in heart failure with preserved ejection fraction Circulation 126 2012 830 839
    • (2012) Circulation , vol.126 , pp. 830-839
    • Van Heerebeek, L.1    Hamdani, N.2    Falcao-Pires, I.3
  • 13
    • 84879748718 scopus 로고    scopus 로고
    • A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation
    • W.J. Paulus, and C. Tschope A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation J Am Coll Cardiol 62 2013 263 271
    • (2013) J Am Coll Cardiol , vol.62 , pp. 263-271
    • Paulus, W.J.1    Tschope, C.2
  • 14
    • 79957505763 scopus 로고    scopus 로고
    • Nitrate therapy: New aspects concerning molecular action and tolerance
    • T. Munzel, A. Daiber, and T. Gori Nitrate therapy: new aspects concerning molecular action and tolerance Circulation 123 2011 2132 2144
    • (2011) Circulation , vol.123 , pp. 2132-2144
    • Munzel, T.1    Daiber, A.2    Gori, T.3
  • 15
    • 84856140884 scopus 로고    scopus 로고
    • Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy
    • S. Schwartzenberg, M.M. Redfield, A.M. From, P. Sorajja, R.A. Nishimura, and B.A. Borlaug Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy J Am Coll Cardiol 59 2012 442 451
    • (2012) J Am Coll Cardiol , vol.59 , pp. 442-451
    • Schwartzenberg, S.1    Redfield, M.M.2    From, A.M.3    Sorajja, P.4    Nishimura, R.A.5    Borlaug, B.A.6
  • 16
    • 10744220361 scopus 로고    scopus 로고
    • Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
    • K. Cosby, K.S. Partovi, J.H. Crawford, and et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation Nat Med 9 2003 1498 1505
    • (2003) Nat Med , vol.9 , pp. 1498-1505
    • Cosby, K.1    Partovi, K.S.2    Crawford, J.H.3
  • 17
    • 36248995976 scopus 로고    scopus 로고
    • Nitrite infusion in humans and nonhuman primates: Endocrine effects, pharmacokinetics, and tolerance formation
    • A. Dejam, C.J. Hunter, C. Tremonti, and et al. Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation Circulation 116 2007 1821 1831
    • (2007) Circulation , vol.116 , pp. 1821-1831
    • Dejam, A.1    Hunter, C.J.2    Tremonti, C.3
  • 18
    • 40149087392 scopus 로고    scopus 로고
    • Hypoxic modulation of exogenous nitrite-induced vasodilation in humans
    • A.R. Maher, A.B. Milsom, P. Gunaruwan, and et al. Hypoxic modulation of exogenous nitrite-induced vasodilation in humans Circulation 117 2008 670 677
    • (2008) Circulation , vol.117 , pp. 670-677
    • Maher, A.R.1    Milsom, A.B.2    Gunaruwan, P.3
  • 19
    • 38849162730 scopus 로고    scopus 로고
    • The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
    • J.O. Lundberg, E. Weitzberg, and M.T. Gladwin The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics Nat Rev Drug Discov 7 2008 156 167
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 156-167
    • Lundberg, J.O.1    Weitzberg, E.2    Gladwin, M.T.3
  • 20
    • 84925543787 scopus 로고    scopus 로고
    • Pharmacokinetics, pharmacodynamics, safety, and tolerability of nebulized sodium nitrite (AIR001) following repeat-dose inhalation in healthy subjects
    • P.J. Rix, A. Vick, N.J. Attkins, and et al. Pharmacokinetics, pharmacodynamics, safety, and tolerability of nebulized sodium nitrite (AIR001) following repeat-dose inhalation in healthy subjects Clin Pharmacokinet 54 2015 261 272
    • (2015) Clin Pharmacokinet , vol.54 , pp. 261-272
    • Rix, P.J.1    Vick, A.2    Attkins, N.J.3
  • 22
    • 84884654757 scopus 로고    scopus 로고
    • Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases
    • G.D. Lewis, E. Bossone, R. Naeije, and et al. Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases Circulation 128 2013 1470 1479
    • (2013) Circulation , vol.128 , pp. 1470-1479
    • Lewis, G.D.1    Bossone, E.2    Naeije, R.3
  • 23
    • 18444374462 scopus 로고    scopus 로고
    • Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure
    • C.F. Baicu, M.R. Zile, G.P. Aurigemma, and W.H. Gaasch Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure Circulation 111 2005 2306 2312
    • (2005) Circulation , vol.111 , pp. 2306-2312
    • Baicu, C.F.1    Zile, M.R.2    Aurigemma, G.P.3    Gaasch, W.H.4
  • 24
    • 84903772161 scopus 로고    scopus 로고
    • Right heart dysfunction in heart failure with preserved ejection fraction
    • V. Melenovsky, S.J. Hwang, G. Lin, M.M. Redfield, and B.A. Borlaug Right heart dysfunction in heart failure with preserved ejection fraction Eur Heart J 35 2014 3452 3462
    • (2014) Eur Heart J , vol.35 , pp. 3452-3462
    • Melenovsky, V.1    Hwang, S.J.2    Lin, G.3    Redfield, M.M.4    Borlaug, B.A.5
  • 25
  • 26
    • 81855206158 scopus 로고    scopus 로고
    • Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction
    • P.S. Bhella, A. Prasad, K. Heinicke, and et al. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction Eur J Heart Fail 13 2011 1296 1304
    • (2011) Eur J Heart Fail , vol.13 , pp. 1296-1304
    • Bhella, P.S.1    Prasad, A.2    Heinicke, K.3
  • 27
    • 84875531214 scopus 로고    scopus 로고
    • Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trial
    • M.M. Redfield, H.H. Chen, B.A. Borlaug, and et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 309 2013 1268 1277
    • (2013) JAMA , vol.309 , pp. 1268-1277
    • Redfield, M.M.1    Chen, H.H.2    Borlaug, B.A.3
  • 28
    • 33947728687 scopus 로고    scopus 로고
    • Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration
    • S. Shiva, Z. Huang, R. Grubina, and et al. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration Circ Res 100 2007 654 661
    • (2007) Circ Res , vol.100 , pp. 654-661
    • Shiva, S.1    Huang, Z.2    Grubina, R.3
  • 29
    • 84899430720 scopus 로고    scopus 로고
    • Mechanisms of nitrite bioactivation
    • D.B. Kim-Shapiro, and M.T. Gladwin Mechanisms of nitrite bioactivation Nitric Oxide 38 2014 58 68
    • (2014) Nitric Oxide , vol.38 , pp. 58-68
    • Kim-Shapiro, D.B.1    Gladwin, M.T.2
  • 30
    • 84922367928 scopus 로고    scopus 로고
    • The effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction
    • P. Zamani, D. Rawat, P. Shiva-Kumar, and et al. The effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction Circulation 131 2015 371 380
    • (2015) Circulation , vol.131 , pp. 371-380
    • Zamani, P.1    Rawat, D.2    Shiva-Kumar, P.3
  • 31
    • 84862127206 scopus 로고    scopus 로고
    • Nitrate-nitrite-nitric oxide pathway in pulmonary arterial hypertension therapeutics
    • C.E. Sparacino-Watkins, Y.C. Lai, and M.T. Gladwin Nitrate-nitrite-nitric oxide pathway in pulmonary arterial hypertension therapeutics Circulation 125 2012 2824 2826
    • (2012) Circulation , vol.125 , pp. 2824-2826
    • Sparacino-Watkins, C.E.1    Lai, Y.C.2    Gladwin, M.T.3
  • 32
    • 84865257955 scopus 로고    scopus 로고
    • Pulmonary hypertension due to left heart disease
    • M. Guazzi, and B.A. Borlaug Pulmonary hypertension due to left heart disease Circulation 126 2012 975 990
    • (2012) Circulation , vol.126 , pp. 975-990
    • Guazzi, M.1    Borlaug, B.A.2
  • 33
    • 84881518465 scopus 로고    scopus 로고
    • Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction
    • W.L. Miller, D.E. Grille, and B.A. Borlaug Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction J Am Coll Cardiol HF 1 2013 290 299
    • (2013) J Am Coll Cardiol HF , vol.1 , pp. 290-299
    • Miller, W.L.1    Grille, D.E.2    Borlaug, B.A.3
  • 34
    • 79551510834 scopus 로고    scopus 로고
    • Dietary inorganic nitrate improves mitochondrial efficiency in humans
    • F.J. Larsen, T.A. Schiffer, S. Borniquel, and et al. Dietary inorganic nitrate improves mitochondrial efficiency in humans Cell Metab 13 2011 149 159
    • (2011) Cell Metab , vol.13 , pp. 149-159
    • Larsen, F.J.1    Schiffer, T.A.2    Borniquel, S.3
  • 35
  • 36
    • 84872370686 scopus 로고    scopus 로고
    • Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats
    • S.K. Ferguson, D.M. Hirai, S.W. Copp, and et al. Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats J Physiol 591 2013 547 557
    • (2013) J Physiol , vol.591 , pp. 547-557
    • Ferguson, S.K.1    Hirai, D.M.2    Copp, S.W.3
  • 37
    • 84863807391 scopus 로고    scopus 로고
    • Single-dose pharmacokinetics of different oral sodium nitrite formulations in diabetes patients
    • F.L. Greenway, B.L. Predmore, D.R. Flanagan, and et al. Single-dose pharmacokinetics of different oral sodium nitrite formulations in diabetes patients Diabetes Technol Ther 14 2012 552 560
    • (2012) Diabetes Technol Ther , vol.14 , pp. 552-560
    • Greenway, F.L.1    Predmore, B.L.2    Flanagan, D.R.3
  • 38
    • 84927712448 scopus 로고    scopus 로고
    • Nitrate's effect on activity tolerance in heart failure with preserved ejection fraction trial: Rationale and design
    • R. Zakeri, J.A. Levine, G.A. Koepp, and et al. Nitrate's effect on activity tolerance in heart failure with preserved ejection fraction trial: rationale and design Circ Heart Fail 8 2015 221 228
    • (2015) Circ Heart Fail , vol.8 , pp. 221-228
    • Zakeri, R.1    Levine, J.A.2    Koepp, G.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.